Carbenicillin treatment of Pseudomonas pulmonary infection. Use in children with cystic fibrosis.
D000293:Adolescent; D000410:Alanine Transaminase / Q000097:blood; D000667:Ampicillin / Q000627:therapeutic use; D001219:Aspartate Aminotransferases / Q000097:blood; D001772:Blood Cell Count; D002648:Child; D002675:Child, Preschool; D004796:Clinical Enzyme Tests; D003091:Colistin / Q000627:therapeutic use; D003550:Cystic Fibrosis / Q000150:complications / Q000188:drug therapy* / Q000382:microbiology; D004357:Drug Synergism; D005839:Gentamicins / Q000627:therapeutic use; D006801:Humans; D010068:Oxacillin / Q000627:therapeutic use; D010406:Penicillins / Q000009:adverse effects / Q000627:therapeutic use*; D011113:Polymyxins / Q000627:therapeutic use; D011552:Pseudomonas Infections / Q000150:complications / Q000188:drug therapy* / Q000382:microbiology; D011550:Pseudomonas aeruginosa / Q000187:drug effects / Q000302:isolation & purification*; D013183:Sputum / Q000382:microbiology; D013752:Tetracycline / Q000627:therapeutic use
D005839:Gentamicins; D010406:Penicillins; D011113:Polymyxins; D000667:Ampicillin; D001219:Aspartate Aminotransferases; D000410:Alanine Transaminase; D013752:Tetracycline; D010068:Oxacillin; D003091:Colistin